marzeptacog alfa (activated): Clinical Trials

1 trial of marzeptacog alfa (activated), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow marzeptacog alfa (activated): new trials by email Literature Review of marzeptacog alfa (activated) trials Research Report on marzeptacog alfa (activated)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia
MarzAA (marzeptacog alfa [activated]) - Hemophilia A, Hemophilia B
Phase 1CompletedCatalyst Biosciences112019-09-242021-09-13

Conditions studied

Hemophilia A (1)  ·  Hemophilia B (1)

Sponsors

Catalyst Biosciences (1)

Countries

Bulgaria (1)  ·  Russia (1)

Top investigators

Howard Levy, MD, PhD, MMM (1)